by The global eclinical solutions market size was valued at USD 6.2 billion in 2020, and is predicted to be worth around USD 20.8 billion by 2030, registering a CAGR of 12.6% during the forecast period 2022 to 2030.
eClinical Solutions Market (By Product: Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Data Integration Platforms, Electronic Clinical Outcome Assessment (eCOA), Safety Solutions, Electronic Trial Master File (eTMF); By Delivery Mode: Web-hosted (On demand), Licensed Enterprise (On premise), Cloud-based; By Development Phase: Phase I, Phase II, Phase III, Phase IV; By End-use: Hospitals/Healthcare providers, CROs, Academic Institutes, Pharma & Biotech Organizations, Medical Device Manufacturers) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2022 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/39114
Report Coverage
| Report Scope | Details |
| Market Size | US$ 20.8 billion by 2030 |
| Growth Rate | CAGR of 12.6% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Delivery mode, Development Phase, End-use |
Growth Factors
Increasing R&D activities by biopharma and pharma companies, application of software solutions in clinical trials, and expanding customer base are anticipated to fuel market growth. During the COVID-19 pandemic, clinical laboratories experienced high demand for COVID-19 tests. eClinical solutions, such as the clinical data management systems assisted these laboratories to seamlessly manage the huge influx of specimens daily. Technological advancements such as electronic data capture and Wi-Fi connectivity are projected to drive the market in the forthcoming years.
Increasing research and development activities by biopharma and pharma companies is one of the key trends escalating market growth. Besides this, the growing incorporation of software solutions in clinical trials is also projected to provide a fillip to the market. The COVID-19 pandemic boosts the adoption of the market, as companies in the market were investing in better healthcare IT solutions to help in tackling the pandemic.
Key Players
- Datatrak International, Inc.
- Oracle
- Parexel International Corporation
- Dassault Systemes
- Bioclinica
- CRF Health
- ERT Clinical
- eClinicalWorks
- IBM Watson Health
- Anju Life Sciences Software
- eClinical Solutions
Market Segmentation
- By Product
- Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
- Clinical Trial Management Systems (CTMS)
- Clinical Analytics Platforms
- Randomization and Trial Supply Management (RTSM)
- Clinical Data Integration Platforms
- Electronic Clinical Outcome Assessment (eCOA)
- Safety Solutions
- Electronic Trial Master File (eTMF)
- By Delivery Mode
- Web-hosted (On demand)
- Licensed Enterprise (On premise)
- Cloud-based
- By Development Phase
- Phase I
- Phase II
- Phase III
- Phase IV
- By End-use
- Hospitals/Healthcare providers
- CROs
- Academic Institutes
- Pharma & Biotech Organizations
- Medical Device Manufacturers
- Regional
- North America
- U.S.
- Canada
- Mexico
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Netherlands
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- New Zealand
- Taiwan
- Hong Kong
- Singapore
- Thailand
- Vietnam
- Central & South America
- Brazil
- Argentina
- Chile
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Egypt
- Qatar
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39114
Reasons to Purchase this Report:– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Development Phase Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global EClinical Solutions Market, By Product
7.1. EClinical Solutions Market, by Product, 2021-2030
7.1.1. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS)
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Clinical Trial Management Systems (CTMS)
7.1.2.1. Market Revenue and Forecast (2019-2030)
7.1.3. Clinical Analytics PlatDelivery Modes
7.1.3.1. Market Revenue and Forecast (2019-2030)
7.1.4. Randomization and Trial Supply Management (RTSM)
7.1.4.1. Market Revenue and Forecast (2019-2030)
7.1.5. Clinical Data Integration PlatDelivery Modes
7.1.5.1. Market Revenue and Forecast (2019-2030)
7.1.6. Electronic Clinical Outcome Assessment (eCOA)
7.1.6.1. Market Revenue and Forecast (2019-2030)
7.1.7. Safety Solutions
7.1.7.1. Market Revenue and Forecast (2019-2030)
7.1.8. Electronic Trial Master File (eTMF)
7.1.8.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global EClinical Solutions Market, By Delivery Mode
8.1. EClinical Solutions Market, by Delivery Mode, 2021-2030
8.1.1. Web-hosted (On demand)
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Licensed Enterprise (On premise)
8.1.2.1. Market Revenue and Forecast (2019-2030)
8.1.3. Cloud-based
8.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global EClinical Solutions Market, By Development Phase
9.1. EClinical Solutions Market, by Development Phase, 2021-2030
9.1.1. Phase I
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Phase II
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Phase III
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Phase IV
9.1.4.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global EClinical Solutions Market, By Application
10.1. EClinical Solutions Market, by Application, 2021-2030
10.1.1. Hospitals/Healthcare providers
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. CROs
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Academic Institutes
10.1.3.1. Market Revenue and Forecast (2019-2030)
10.1.4. Pharma & Biotech Organizations
10.1.4.1. Market Revenue and Forecast (2019-2030)
10.1.5. Medical Device Manufacturers
10.1.5.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global EClinical Solutions Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.1.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.1.4. Market Revenue and Forecast, by Application (2019-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.1.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.1.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.1.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.1.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.7.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.8.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.2.8.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.2.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.7.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.8.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.3.8.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.3.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.6.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.7.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.7.4. Market Revenue and Forecast, by Application (2019-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.8.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.4.8.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.4.8.4. Market Revenue and Forecast, by Application (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.5.5.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.5.5.4. Market Revenue and Forecast, by Application (2019-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2030)
11.5.6.3. Market Revenue and Forecast, by Development Phase (2019-2030)
11.5.6.4. Market Revenue and Forecast, by Application (2019-2030)
Chapter 12. Company Profiles
12.1. Datatrak International, Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Oracle
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Parexel International Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Dassault Systemes
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bioclinica
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CRF Health
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. ERT Clinical
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. eClinicalWorks
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. IBM Watson Health
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Anju Life Sciences Software
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/39114
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
